Page last updated: 2024-11-02

pd 153035 and Cancer of Prostate

pd 153035 has been researched along with Cancer of Prostate in 5 studies

4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline: structure given in first source
PD-153035 : A member of the class of quinazolines carrying a 3-bromophenylamino substituent at position 4 and two methoxy substituents at positions 6 and 7.

Research Excerpts

ExcerptRelevanceReference
"In vivo, the human prostate cancer xenografts in mouse war accurately visualized after i."1.36Synthesis and initial tumor affinity testing of iodine-123 labelled EGFR-affine agents as potential imaging probes for hormone-refractory prostate cancer. ( Fozing, T; Samnick, S; Scheuer, C, 2010)
"Because the prostate and breast cancer lines usually present autocrine stimulatory loops involving EGFR, we also examined transgenic adenocarcinoma mouse prostate C1 and MDA-468 treated with the EGFR-specific kinase inhibitor PD153035 to determine whether invasiveness is dependent on EGFR signaling."1.30A role for phospholipase C-gamma-mediated signaling in tumor cell invasion. ( Greenberg, NM; Kassis, J; Kim, HG; Lo, H; Moellinger, J; Wells, A, 1999)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abisoye-Ogunniyan, A1
Lin, H1
Ghebremedhin, A1
Salam, AB1
Karanam, B1
Theodore, S1
Jones-Trich, J1
Davis, M1
Grizzle, W1
Wang, H1
Yates, C1
Fozing, T1
Scheuer, C1
Samnick, S1
Mimeault, M1
Pommery, N1
Hénichart, JP1
Bos, M1
Mendelsohn, J1
Kim, YM1
Albanell, J1
Fry, DW1
Baselga, J1
Kassis, J1
Moellinger, J1
Lo, H1
Greenberg, NM1
Kim, HG1
Wells, A1

Other Studies

5 other studies available for pd 153035 and Cancer of Prostate

ArticleYear
Transcriptional repressor Kaiso promotes epithelial to mesenchymal transition and metastasis in prostate cancer through direct regulation of miR-200c.
    Cancer letters, 2018, 09-01, Volume: 431

    Topics: Animals; Cell Line, Tumor; Cell Proliferation; DNA Methylation; Epidermal Growth Factor; Epithelial-

2018
Synthesis and initial tumor affinity testing of iodine-123 labelled EGFR-affine agents as potential imaging probes for hormone-refractory prostate cancer.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:9

    Topics: Animals; Antibodies, Monoclonal; Biological Transport; Cell Line, Tumor; Drug Resistance, Neoplasm;

2010
Synergistic antiproliferative and apoptotic effects induced by epidermal growth factor receptor and protein kinase a inhibitors in human prostatic cancer cell lines.
    International journal of cancer, 2003, Aug-10, Volume: 106, Issue:1

    Topics: Amino Acid Chloromethyl Ketones; Apoptosis; Cell Division; Cell Separation; Ceramides; Cyclic AMP; C

2003
PD153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number-dependent manner.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1997, Volume: 3, Issue:11

    Topics: Adenocarcinoma; Breast Neoplasms; Carcinoma, Squamous Cell; Colonic Neoplasms; Enzyme Inhibitors; Er

1997
A role for phospholipase C-gamma-mediated signaling in tumor cell invasion.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:8

    Topics: Adenocarcinoma; Animals; Autocrine Communication; Breast Neoplasms; Cell Line; Diffusion Chambers, C

1999